
George Lundberg, MD Editor in Chief at Cancer Commons
-
March 8, 2022
Using Protein Analysis to Understand Esophageal Cancer Bookmark
George Lundberg, MDIn order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.
.
.
-
March 8, 2022
National Colorectal Cancer Awareness Month Bookmark
George Lundberg, MDMarch 2022 is Colorectal Cancer Awareness Month in the U.S., as recognized by The White House.
.
-
March 8, 2022
The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary Bookmark
George Lundberg, MDDiagnosis is the basis for all treatments. As outlined in the scientific journal Neuro-Oncology, the World Health Organization (WHO) issued a new classification of central nervous system malignancies in 2021, outlining new standards for diagnosis.
.
-
March 8, 2022
Hepatocellular Carcinoma in 2021: An Exhaustive Update Bookmark
George Lundberg, MDThis exhaustive scientific review was published by Cureus in 2021, but remains relevant now. It explores current molecular understanding of hepatocellular carcinoma—the most common type of cancer that starts in the liver—as well as a very large range of diagnostic and treatment options.
.
-
March 8, 2022
New Clinical Trial Results for Pembrolizumab in Triple-Negative Breast Cancer Bookmark
George Lundberg, MDAs reported in the medical research journal The Lancet, adding the drug pembrolizimab (Keytruda) to chemotherapy increased progression-free survival—both clinically and statistically—for clinical trial participants with advanced breast cancer.
.
-
March 8, 2022
Immunotherapy Before Targeted Therapy Extends OS in Metastatic Melanoma Bookmark
George Lundberg, MDAs reported by Healio, immunotherapy followed by targeted therapy improved overall survival in a clinical trial with metastatic melanoma patients.
.
-
February 18, 2022
Learn More About Qualifying for Clinical Trials Bookmark
George Lundberg, MDClinical trials can be of great importance for patients with cancer. Here is some sound background information from Cancer Commons partner Let’s Win! Pancreatic Cancer.
.
-
February 18, 2022
Mental Health and Pancreatic Cancer Bookmark
George Lundberg, MDCoping with a potentially lethal cancer presents many serious challenges. This article from Cancer Commons partner Let’s Win! Pancreatic Cancer might help.
.
-
February 18, 2022
Palliative Care Options for a Young Adult Patient with a Diffuse Intrinsic Pontine Glioma Bookmark
George Lundberg, MDThis clinical case study published in the scientific journal Cureus suggests that intelligent, compassionate, palliative care is likely the best approach to this very difficult brain tumor.
.
-
February 18, 2022
DIPG All-In-Initiative Awards $35,000 Grant for Pediatric Brain Tumor Research Bookmark
George Lundberg, MDAs announced by Cancer Commons partner the Musella Foundation For Brain Tumor Research & Information, Inc., a collaboration of groups has announced funding to support research into possible treatments for pediatric diffuse intrinsic pontine glioma (DIPG).
.